AI · Health

Lumonus

Health · Headquartered in Australia 🇦🇺

Website

lumonus.com

HQ Country

🇦🇺 Australia

/lumonus

Careers

No public jobs page

Track Lumonus — get Health deals in free daily digest

Overview

Lumonus, an AI-powered radiation oncology workflow solutions company based in Sydney, raised $25 million in Series B funding, led by Aviron Investment Management with participation from Oncology Ventures. The funds will be used to expand operations and enhance development efforts.

Products

Synthesising company profile

Reading press coverage to extract founders, customers, traction signals and competitive positioning…

Recent Announcements

Lumonus Raises $25M in Series B Funding

Lumonus Raises $25M in Series B Funding (FINSMEs)

More Health Deals

Company		Deal	Headline	Date
Betterness	🇺🇸	$2.5M	Betterness: $2.5 Million Raised To Launch Voice-First Autonomous AI Life Coaching Platform	26 Apr 2026
10x Science	🇺🇸	$4.8M	10x Science: $4.8 Million Raised To Build AI Platform For Molecular Protein Characterization Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor	26 Apr 2026
Bioxtreme	🇮🇱	$15M	Bioxtreme: Strategic Investment From Serra Holding And Plaxtreme Launch Advance Neurorehabilitation Robotics Serra Holding	23 Apr 2026
Courier Health	🇺🇸	$50M	Courier Health: $50 Million Series B Fuels AI-Driven Patient Experience Platform For Biopharma Oak HC/FT, Norwest, Work-Bench	22 Apr 2026
Amperos Health	🇺🇸	$16M	Amperos Health: $16 Million Series A Funds AI-Driven Denial Management Platform Launch Bessemer Venture Partners, Uncork Capital, Neo	22 Apr 2026
Calibre	🇬🇧	$3.024M	Uk HealthTech Startup Calibre Raises €2.8M Funding In Pre-Seed Round Amino Collective, Daybreak Ventures, Cocoa Ventures, Timo Boldt, Maximilian Tayenthal	22 Apr 2026
Arlo Technologies	🇺🇸	—	Arlo Technologies: Acquisition Of Aloe Care Health Expands AI-Powered Platform Into Aging-In-Place Care	20 Apr 2026
Coral	🇺🇸	$12.5M	Coral raises $12.5M for healthcare automation Lightspeed,Z47	20 Apr 2026
Alloy Therapeutics	🇺🇸	$40M	Alloy Therapeutics: $40 Million Series E At $1 Billion Valuation Raised To Scale AI-Driven Biotech Infrastructure 8VC, JIC Venture Growth Investments, Echo Capital, Mubadala Capital, Thiel Capital	19 Apr 2026
Biolamina	🇸🇪	$21.6M	Stockholm’s BioLamina Raises €20M EIB Loan To Scale Cell Therapy Development	17 Apr 2026